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Abstract 
Background: MAGEL2-associated Schaaf-Yang syndrome (SHFYNG, OMIM #615547, ORPHA: 398069), which was 
identified in 2013, is a rare disorder caused by truncating variants of the paternal copy of MAGEL2, which is localized in 
the imprinted region on 15q11.2q13. The phenotype of SHFYNG in childhood partially overlaps with that of the well-
established Prader–Willi syndrome (PWS, OMIM #176270). While larger numbers of younger individuals with SHFYNG 
have been recently published, the phenotype in adulthood is not well established. We recruited 7 adult individuals 
(aged 18 to 36) with molecularly confirmed SHFYNG and collected data regarding the clinical profile including eating 
habits, sleep, behavior, personal autonomy, psychiatric abnormalities and other medical conditions, as well as infor-
mation about the respective phenotypes in childhood.
Results: Within our small cohort, we identified a range of common features, such as disturbed sleep, hypoactivity, 
social withdrawal and anxiety, but also noted considerable differences at the level of personal autonomy and skills. 
Behavioral problems were frequent, and a majority of individuals displayed weight gain and food-seeking behavior, 
along with mild intellectual disability or borderline intellectual function. Classical symptoms of SHFYNG in childhood 
were reported for most individuals.
Conclusion: Our findings indicate a high variability of the functional abilities and social participation of adults with 
SHFYNG. A high prevalence of obesity within our cohort was notable, and uncontrollable food intake was a major 
concern for some caregivers. The phenotypes of PWS and SHFYNG in adulthood might be more difficult to discern 
than the phenotypes in childhood. Molecular genetic testing for SHFYNG should therefore be considered in adults 
with the suspected diagnosis of PWS, if testing for PWS has been negative.
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Background
The MAGEL2-associated Schaaf-Yang syndrome 
(SHFYNG; OMIM #615547, ORPHA:  398069) is 
a rare hereditary neurodevelopmental disorder 
(prevalence < 1/1,000,000) with a profound impact on 
global development. The syndrome is usually evident at 
birth, with contractures of the interphalangeal joints, 
hypotonia and poor suck as characteristic early features. 
Global developmental delay usually becomes evident 
during infancy and intellectual disability of variable 
severity is present in all cases reported to date [1]. 
Hormonal anomalies such as hypogonadism and growth 
hormone deficiency are also part of the spectrum and 
some of the clinical features of SHFYNG mimic those 
observed in individuals with Prader–Willi Syndrome 
(PWS) [1–3]. PWS and SHFYNG are related disorders 
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on the molecular level, as MAGEL2 is among the genes 
located within the PWS critical region on 15q11.2-q13 
[4–6]. The clinical picture of PWS is usually marked by 
neonatal hypotonia and poor suck in infancy, but children 
often develop hyperphagia and begin to gain weight from 
the third year of life onwards, with a high risk of morbid 
obesity and associated medical complications persisting 
throughout adulthood [7]. Unlike PWS, this hyperphagic 
phase is not a hallmark of SHFYNG in childhood, and 
has previously only been reported in 25% of individuals 
[1]. Developmental delay is usually more pronounced in 
children with SHFYNG compared to children with PWS, 
and criteria for autism spectrum disorder (ASD) are more 
frequently met (78% vs 26.7% [3, 8]). Both disorders are 
associated with clinical symptoms and variable degrees 
of disability in adulthood. While the phenotype of adults 
with PWS has been the subject of research over decades 
[9–12], clinical, social and behavioral traits of adults with 
SHFYNG have not been systematically studied. With 
the increasing availability of exome sequencing and its 
application in individuals with intellectual disability, the 




In this study, we investigated the phenotypes of 7 adult 
individuals with molecularly confirmed SHFYNG 
(individuals #1–7, who carry a truncating variant on 
the paternal MAGEL2 allele) and one individual with 
the clinical phenotype of SHFYNG and a variant of 
unknown significance in MAGEL2 (individual #8). We 
used a standardized questionnaire and, if available, 
clinical records from childhood onwards, with the aim 
to (1) characterize the adult phenotype of SHFYNG, (2) 
compare the adult phenotypes of SHFYNG and PWS, and 
(3) discern possible correlations between development in 
childhood and the phenotype in adulthood.
Individuals with SHFYNG and their families were 
recruited at the following institutions: University 
Hospital Cologne, Cologne (Germany), University 
Hospital Essen, Essen (Germany), Baylor College of 
Medicine, Houston (US), and Maastricht University 
Medical Center, Maastricht (the Netherlands). The 
study was also announced to members of the SHFYNG 
Facebook group (https ://www.faceb ook.com/MAGEL 
2). Individuals with SHFYNG and their relatives and/
or legal guardians from the United States (n = 4), 
Germany (n = 3), and the Netherlands (n = 1) expressed 
willingness to participate, and subsequently received 
the questionnaire. The legal guardians of all participants 
provided signed consent under the IRB-approved human 
research protocol H-34578, Baylor College of Medicine. 
Data regarding individuals #4 and #5 at a younger age 
had been previously published [1, 13].
Molecular analysis
A description of the methods applied for molecular 
genetic testing in individuals #1–8 can be found in the 
Additional file 1.
Results
Adult individuals and their respective family members 
and/or legal guardians received a questionnaire (see 
Additional file 1) which was divided into sections includ-
ing eating habits, behavior, autonomy, as well as psychi-
atric and other medical conditions. Clinical records from 
childhood were also collected and compiled (Table  1). 
The questionnaire can be found in the Additional file 1. 
compilation of clinical photographs of individuals #2, #5, 
#6, and #7 can be found in Figs.  1 and 2. We excluded 
individual #8 from the compilation, as the diagno-
sis of SHFYNG, while likely, could not be molecularly 
confirmed.
Phenotype in childhood
Most individuals of our cohort had a typical presentation 
of SHFYNG at birth, with neonatal hypotonia, feeding 
difficulties and contractures of the interphalangeal 
joints in 6 out of 7 individuals. Motor and language 
development was delayed in all cases, and 2 out of 7 
individuals displayed excessive weight gain before the age 
of 6  years. Notable were behavioral difficulties already 
in childhood with frequent tantrums, anger outbreaks, 
social withdrawal, and in at least one case aggressive 
behavior during puberty. All patients demonstrated mild 
intellectual disability to low normal intelligence.
Our data regarding the adult phenotype of patient #1–7 
can be subdivided into 4 main areas:
1 Food intake, body weight and sleep
Among the most challenging symptoms for both 
individuals and their family members was excessive 
weight gain, leading to obesity (BMI > 30 kg/m2) in 5 out 
of 7 individuals. Overeating and food-seeking behavior 
was present in all individuals with obesity. Constipation 
of varying severity, a frequent feature in children with 
SHFYNG [1], was present in 5 out of 7 adult individuals 
except for individual #7 and individual #3 (who has an 
intragastric PEG/ MIC-KEY tube).
A disturbed sleep cycle with daytime fatigue was 


































Table 1 Overview of  the  reported phenotypic features of  individuals #1–#8 in  childhood, as  well as  the  respective phenotypes in  adulthood including  food 
intake, behavior, autonomy, and medical conditions
Individual # 1 2 3 4 5 6 7 8
Age (years) 25 30 26 20 18 18 36 55
Gender F M F M M F F M
MAGEL2 variant 
(NM_019066.4)
















Inheritance De novo De novo Paternal De novo Paternal Unknown Unknown Unknown
Height (cm) 144.8 170 n.s 175.9 148 174 147 160
BMI (kg/m2) 31.4 41.2 n.s 30.6 22 31.7 32 51.6
Head circumference (cm) n.s 56 n.s n.s n.s 54 55 57




n.s./n.a Learning disability 
(WAIS-IV full scale: 
84)
n.s Learning disability 
(74–85)




Birth weight (kg) 2.35 3.33 2.61 n.s 2.89 3.42 3.28 n.s
Birth length (cm) n.s 50 n.s n.s 48.3 54 46 n.s
Head circumference (cm) n.s 36.5 32.7 n.s n.s 36 n.s n.s
Gestational week 35 40 35 n.s n.s 40 38 n.s
Decreased fetal 
movement
n.s Yes n.s n.s n.s Yes n.s n.s
Congenital contractures of 
interphalangeal joints
Yes Yes Yes Yes Yes No Yes n.s
Neonatal hypotonia, poor 
suck
Yes Yes Yes Yes Yes Yes No n.s
Feeding problems in 
infancy
Yes Yes Yes Yes Yes Yes No Yes
Nasogastric tube feeding n.s Yes Yes n.s Yes Yes, for 1 mo No n.s
Motor development Delayed Delayed Severely delayed, 
never walked
Delayed Delayed Delayed Delayed Delayed
Language development Delayed Delayed None Delayed Delayed Normal n.s n.s
Speech, articulation 
defects
n.s Fluent, mild 
(sometimes 
slurred speech)
n.a n.s First words at 
11 years of age
Fluent Strong verbal 
qualities
Fluent, mild
Excessive weight gain 
before the age of 6 years
n.s Yes No No No Yes n.s Possibly Yes
Phenotype in adulthood
Food intake, metabolism and sleep (− = never; + = 1–3 times/month; ++ = 1–3 times/week; +++ = 4–7 times/week)


































Individual # 1 2 3 4 5 6 7 8
Food-seeking behavior ++ +++ n.a +++ − + + ++
Sleep apnea + +++ − +++ +++ − n.s +++
Need for assisted 
ventilation (CPAP, BIPAP)
− +++ − +++ +++ − − +++
Abnormal sleep  cyclea ++ ++ +++ + +++ + ++ +++
Excessive sleeping/
daytime fatigue
+++ ++ +++ +++ +++ −/+ − ++
Constipation +++ ++ − ++ +++ + − +++
Behavior and psyche (− = not present and/or not an issue; + = infrequent and/or not a big issue; ++ = frequent and/or sometimes a big issue;+++ = almost always present and/or a major 
concern)
Hyperactivity ++ − − + − − − ++
Underactivity ++ +++ − ++ n.s +++ ++ +++
Stubbornness +++ ++ − ++ ++ + ++ +++
Temper tantrums + + − ++ − − − ++
Aggression + − − − − − − ++
Lying, deceitfulness +++ − n.a ++ − − + +
Stealing +++ − n.a ++ − − + ++
Manic, excited mood +++ ++ − − − − − ++
Depressive mood + ++ − + − − − +++
Anxiety ++ + − ++ + +++ + +++
Social withdrawal +++ + n.a + − + + +++
Restricted interests +++ n.s n.a ++ ++ ++ + ++
Self-stimulatory behavior + +++ − − ++ − − +
Skin picking +++ − − + − − + +++
Autonomy and activities




Reading skills Basic Not present Not present Basic Basic Good Good Good
Awareness of danger Severely reduced Reduced Severely reduced Reduced Severely reduced Severely reduced Reduced Normal
Can take care for basic 
 needsb
Yes, but help 
is required in 
certain areas
Sometimes, but 
help is required 
regularly
No Yes, but help 
is required in 
certain areas









































Individual # 1 2 3 4 5 6 7 8
Performs more complex 
(everyday)  activitiesd
No/mostly not No/mostly not No Sometimes No No/mostly not Regularly Sometimes
Sports/physical activities No/mostly not Regularly No Sometimes Sometimes Occasionally No No
Works (e.g. in a 
sheltered  environment)
No/mostly not Regularly No Regularly No Regularly Regularly No
Medical conditions, medication
Hypothyroidism No Yes No Yes No No No Yes
Hypogonadisme n.s Yes Yes No No No No Yes
Type 2 diabetes No No No No No No No No
Hypertension No No No No No No No Yes
Scoliosis Yes Yes Yes No Yes No Yes No
Autism spectrum disorder Yes No n.a Yes Yes Yes (Rocking body 
movements)
No No
Attention deficit disorder Yes No (?) n.a n.s n.s n.s No n.s
Obsessive compulsive 
disorder
Yes No (?) n.a Yes n.s n.s No No
Growth hormone therapy Yes No No No Yes No No No
Use of melatonin No No No Yes No No No No
n.s. not specified, n.a. not applicable
a A sleeping routine that is different from the normal sleep cycle (e.g. sleeping from 2 pm to 1 am). A “reverse” sleep cycle would be the most extreme form
b E.g. getting dressed, using the toilet, basic body hygiene
c E.g. cleaning his or her room, preparing food
d E.g. buying groceries, or using public transport
e Defined as repeatedly low levels of sex hormones
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Fig. 1 Clinical photographs of adult individuals with SHFYNG syndrome and evolution of the facial phenotype over time. Individual #2 at the age 
of 3 years (a), 5.5 years (b), 11.5 years (c) and 28 years (d, e). Individual #5 at the age of 2 years (f), 11 years (g), and 18 years (h, i). Individual #6 at the 
age of 5 years (j), 10 years (k), and 18 years (l, m). Individual #7 at age 9 (n, o), and 34 years (p, q)
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from trouble sleeping through, which is present to 
variable extent in all individuals, to a completely dis-
organized sleep pattern in the case of individual #3. 
Sleep apnea was reported in 4 individuals, necessitat-
ing assisted ventilation during night-time for 3 out of 4 
individuals. While increased BMI is linked to a higher 
prevalence of obstructive sleep apnea in the general 
population, the presence of sleep apnea does not exclu-
sively correlate with obesity in our cohort. This finding 
is in accordance with a high rate of obstructive as well 
as central sleep apnea reported in younger SHFYNG 
individuals, the majority of whom did not display 
excessive weight gain at the time of data collection [1].
2. Behavioral phenotype
Formal intelligence testing, if performed, produced 
results compatible with mild intellectual disability (ID) or 
low-normal intelligence, although no formal testing of the 
more severely affected individuals had been performed. 
The majority of individuals in our cohort showed features 
associated with autism spectrum disorder (ASD) with 
restricted and sometimes obsessive interests reported 
Fig. 2 Clinical photographs of individuals with SHFYNG syndrome. Individual #2: facial profile at age 28 years (a), hands at age 3.5 years (b), hands 
and feet at age 28 years (c–e). Individual #6: facial profile, hands and feet at age 18 years (f–i), Individual #7: facial profile and hands at age 9 (j, k), 
hands and feet at age 34 years (l–n)
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in 5 individuals. These interests included relatively 
simple obsessions like a fascination with insects, as well 
as more complex activities such as computer games. 
Social withdrawal was reported in 5 out of 7 individuals, 
and 3 individuals displayed self-stimulatory behavior. 
Another prominent behavioral feature was lack of 
activity and initiative (5 individuals). While stubbornness 
(6 individuals) and mostly occasional temper tantrums 
(3 individuals) were reported, most individuals did not 
show aggressive behavior. Infrequent bouts of aggression 
in response to an external restriction of obsessive 
interests, or unwanted changes of environment, were 
only reported in individual #1. It is also notable that 6 out 
of 7 individuals suffered from anxiety of varying severity. 
In the case of individual #4, episodes of high anxiety 
preceded the onset of common respiratory infections.
3. Autonomy and activities
The capabilities of individuals in our cohort differed 
considerably. While 5 individuals communicated verbally, 
individual #5 relied on signs and gestures, and no 
systematic mode of communication had been established 
in the case of individual #3. Additionally, 5 individuals 
had at least basic reading skills. All individuals required 
some external help with basic self-care such as dressing 
and body hygiene, and 2 individuals (#3 and 5) were fully 
reliant on external help in their daily life. Concerning 
everyday activities, 3 individuals (# 2, 4 and 7) performed 
housekeeping chores, while individuals #4 and #7 
engaged in several more complex tasks. A total of 4 
individuals participated in sports or physical activities 
to some extent. Additionally, 4 individuals worked in a 
protected environment on a regular basis. All individuals 
lived in specialized institutions or at home with their 
families. A reduced or severely reduced awareness of 
danger was reported in all individuals of our cohort.
4. Medical conditions
Neither type 2 diabetes nor hypertension was 
reported in any of the 5 individuals with BMI > 30  kg/
m2 (individuals # 1, 2, 4, 6 and 7, aged 18–36  years). 
Individual #2, for whom overeating and obesity had 
been a constant concern since childhood, had normal 
fasting glucose and insulin levels, as well as a normal 
oral glucose tolerance test at the age of 19  years 
(BMI 34.1  kg/m2). Repeated measurements of fasting 
glucose in individual #6 also produced normal results. 
Hypothyroidism was noted in individuals #2 (30 years) 
and #4 (20 years) of our cohort. This feature, which is 
present in roughly 25% of individuals with PWS [5], 
had not been previously found in younger individuals 
with SHFYNG [3] (aged 0.5–18 years). Hypogonadism 
was observed in 2 individuals. Scoliosis was present 
in 5 individuals, and individual #3 showed evidence 
for bone fragility (repeated fractures of the femur). 
Individuals #1 and #5 received growth hormone 
therapy, and individual #4 melatonin therapy for the 
treatment of a sleeping disorder. ASD was diagnosed 
in 4, and obsessive–compulsive disorder (OCD) was 
diagnosed in 2 individuals. Individual #6 was diagnosed 
with paranoid schizophrenia, which was treated 
with antipsychotic medication (Aripiprazole and 
Amisulpride).
Individual #8
Individual #8 first presented at the age of 55  years. 
Clinical records indicated feeding difficulties in infancy, 
developmental delay and learning difficulties, as well 
as the onset of hyperphagia in childhood. The patient 
presented with mild intellectual disability, and personnel 
of his specialized institution reported behavioral 
problems including bouts of aggression, chronic 
skin picking and uncontrolled eating. He had been 
hospitalized once due to a major depressive episode. 
Clinical examination revealed low height (160  cm), 
obesity (BMI 51.6), and hypoplastic genitalia. He had 
tapering fingers with scarred finger tips. The clinically 
suspected diagnosis of PWS could not be molecularly 
confirmed by chromosome array-comparative-genomic-
hybridization or methylation-sensitive MLPA. Targeted 
sequence analysis of MAGEL2 then revealed an in-frame 
duplication of 63 base pairs (c.2170_2232dup; p.(Ser724_
Ala744dup). This variant was located on the paternal 
allele (confirmed by methylation-sensitive testing), but 
was classified as a variant of unknown significance, as 
only frameshift- or stop-variants of MAGEL2 have so far 
been reported as pathogenic, and it is present 2 times 
in gnomAD v3 [14]. Additional genetic testing such as 
exome sequencing had not been performed, and family 
members were not available for segregation analysis. 
Regarding the presence of the variant c.2170_2232dup 
in gnomAD, it should be noted that it is unknown if the 
respective individuals carry the variant on the paternal 
or the maternal allele. Since only pathogenic variants of 
MAGEL2 which are located on the paternal allele will 
cause the SHFYNG phenotype, pathogenic frameshift 
or stop variants of this gene can be found at extremely 
low frequencies in the gnomAD v2.1.1 and v3 datasets 
(see Web resources), which represent a (mostly) healthy 
control population. As individual #8 presented with 
hallmark symptoms of SHFYNG, we nevertheless 
suspect this diagnosis to be present. An overview of the 
phenotype of individual #8 can be found in Table 1.
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Discussion
Schaaf-Yang syndrome was initially described in patient 
cohorts consisting predominantly of children, while 
adults with SHFYNG have been underrepresented. 
Adult individuals with MAGEL2 mutations have been 
reported in the literature, such as the cases presented 
by Jobling et  al. (individual I-1) [15], or Fountain et  al. 
(individual 18) [13], but a systematic investigation of 
adults with this disorder has not been done previously. 
The phenotypes observed in these individuals are highly 
variable, especially with regard to the degree of personal 
independence and social participation, ranging from 
semi-autonomous living (individual #4) to complete 
dependence on external help (individual #3). However, 
most individuals acquired verbal communication skills 
and participated in social activities like sports or games, 
and 4 out of 7 individuals worked on a regular basis, 
albeit in protected work environments. Major concerns 
of the relatively high-performing individuals and 
their families were overeating and subsequent weight 
problems, although complications like hypertension 
and type 2 diabetes were yet to manifest. Reduced 
activity and fatigue negatively impacted the daily life of 
most individuals, and heightened anxiety was reported 
almost unanimously among the cohort. Additionally, 
the prevalence of psychiatric disorders (ASD, OCD, 
paranoid schizophrenia) was high (4 out of 7 individuals). 
There was a general trend towards an exacerbation of 
social withdrawal and behavioral abnormalities with 
progressing age. The pubertal period proved particularly 
testing for families and caregivers.
The cognitive ability of individuals of our small cohort 
was mostly within the range of mild intellectual disability 
or borderline intellectual function, which is inconsistent 
with previous findings from a larger cohort of younger 
individuals, where the average IQ was within the range of 
moderate intellectual disability [1]. Possible explanations 
for this might be the small sample size, or the presence 
of a selection bias, for example due to a higher overall 
childhood mortality in more severely affected individuals.
A notable similarity between adults with SHFYNG and 
PWS is a high prevalence of obesity and food-seeking 
behavior, although this symptom is not present in all 
individuals of our cohort. Overeating could be observed 
in individuals with a higher degree of independence and 
verbal communication skills (individuals # 1, 2, 4, 6 and 
7), and it is absent in the individuals who are in need 
of external help for basic self-care and where verbal 
communication is not possible (individuals # 3 and 5).
Children with SHFYNG display a characteristic 
combination of symptoms, with marked differences 
between SHFYNG and PWS. These include the 
prevalence of contractures at birth, a more pronounced 
developmental delay, a lower rate and later onset of 
hyperphagia in childhood, and a higher prevalence 
of autistic features [1, 3, 16]. The onset of obesity in 
individuals with SHFYNG, while highly variable, seems 
to occur generally later in life than the onset of obesity 
in individuals with PWS (6–12  years [6]). Given the 
generally slower global development and lower cognitive 
ability of individuals with SHFYNG compared to PWS [1, 
5, 17], one possible explanation for this observation might 
be an inability to independently acquire food rather than 
a lower appetite. Food intake may therefore be better 
controllable in some individuals during childhood, and 
may exacerbate later in life once the individual’s skills and 
cognitive ability allow it. In this case, the onset of obesity 
would be the consequence of a milder phenotype with 
greater cognitive abilities. Alternatively, a greater desire 
for food might simply accompany (and be indicative 
of ) a milder, more PWS-like, course of SHFYNG. Both 
explanations would be compatible with the presence of 
obesity in adults with higher cognitive function, and its 
absence in more severely affected individuals within our 
small cohort.
Another emerging connection between SHFYNG 
and PWS in adulthood might be an increased risk of 
psychiatric disorders. Based on a study of 70 adults 
with PWS living in residential care by Manzardo et  al. 
[18] (mean age 37 ± 10  years), anxiety disorders were 
reported in 38%, and psychotic features including 
schizophrenia had been diagnosed in 23%, while mood 
disorders were also prevalent (major depressive disorder 
in 24%, nonpsychotic bipolar disorder in 21%). The small 
cohort size of our study does not allow a definitive risk 
assessment, but the presence of anxiety in all but one 
individual, and paranoid schizophrenia in 1 individual, 
may indicate a similar pattern of psychiatric disorders in 
adults with SHFYNG.
Conclusions
Our assessment of adults with SHFYNG demonstrated 
a high variability of behavioral characteristics and func-
tional abilities. The level of autonomy ranged from 
complete dependence on external help to semi-auton-
omous living, and cognitive ability was mostly classified 
as mild intellectual disability or borderline intellectual 
function. All individuals had behavioral problems and 
a lack of activity and motivation were frequent, as well 
as abnormalities of the sleep cycle and fatigue. Obe-
sity was present in a majority of cases, and almost all 
participants had the typical phenotype of SHFYNG in 
childhood. Hallmark symptoms of PWS in adulthood 
were present in most individuals, which makes the dis-
tinction between adults with SHFYNG and those with 
the more frequent PWS more difficult. In those cases, 
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information regarding the phenotype in childhood 
(such as contractures at birth, more severely delayed 
development, later onset of hyperphagia), if available, 
might be the most reliable anamnestic tool. To illus-
trate the large phenotypic overlap of both disorders, 
the most prominent features of SHFYNG and PWS in 
adults are shown in Fig. 3. The differential diagnosis of 
SHFYNG should be considered in every adult with the 
suspected diagnosis of PWS, if molecular genetic test-
ing for PWS is negative. Similar to adults with PWS, 
adults with SHFYNG might have a significantly higher 
risk of psychiatric disorders.
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